Pacira Pharmaceuticals buy Wedbush
Start price
08.02.24
/
50%
€25.80
Target price
08.02.25
€53.03
Performance (%)
-52.33%
Price
22.08.24
€12.30
Summary
This prediction is currently active. Massive losses of -52.33% have been the result for the BUY prediction by Wedbush. This prediction currently runs until 08.02.25. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacira Pharmaceuticals | 6.957% | 6.957% |
iShares Core DAX® | 1.665% | 0.362% |
iShares Nasdaq 100 | -0.475% | -3.195% |
iShares Nikkei 225® | 2.620% | 1.174% |
iShares S&P 500 | -0.091% | -1.597% |
Comments by Wedbush for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $57.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat